National Medical Care Management
Management criteria checks 2/4
We currently do not have sufficient information about the CEO.
Key information
Abdulaziz Alobaid
Chief executive officer
ر.س242.0k
Total compensation
| CEO salary percentage | n/a |
| CEO tenure | 6.1yrs |
| CEO ownership | n/a |
| Management average tenure | no data |
| Board average tenure | 5.2yrs |
Recent management updates
Recent updates
National Medical Care (TADAWUL:4005) Might Have The Makings Of A Multi-Bagger
Jan 30
If EPS Growth Is Important To You, National Medical Care (TADAWUL:4005) Presents An Opportunity
Jan 08What National Medical Care Company's (TADAWUL:4005) P/E Is Not Telling You
Dec 12National Medical Care's (TADAWUL:4005) Solid Earnings May Rest On Weak Foundations
Oct 29National Medical Care (TADAWUL:4005) Shareholders Will Want The ROCE Trajectory To Continue
Sep 25Analysts Are Updating Their National Medical Care Company (TADAWUL:4005) Estimates After Its Second-Quarter Results
Aug 06Getting In Cheap On National Medical Care Company (TADAWUL:4005) Is Unlikely
Jul 26National Medical Care Company's (TADAWUL:4005) Shares May Have Run Too Fast Too Soon
Apr 05We Think National Medical Care's (TADAWUL:4005) Robust Earnings Are Conservative
Mar 14National Medical Care (TADAWUL:4005) Is Very Good At Capital Allocation
Mar 13Some Confidence Is Lacking In National Medical Care Company's (TADAWUL:4005) P/E
Dec 27Returns On Capital Are Showing Encouraging Signs At National Medical Care (TADAWUL:4005)
Dec 05We Like These Underlying Return On Capital Trends At National Medical Care (TADAWUL:4005)
Aug 07Is National Medical Care Company (TADAWUL:4005) Worth ر.س107 Based On Its Intrinsic Value?
May 29Investors Will Want National Medical Care's (TADAWUL:4005) Growth In ROCE To Persist
May 08Investors Will Want National Medical Care's (TADAWUL:4005) Growth In ROCE To Persist
Dec 19A Look At The Fair Value Of National Medical Care Company (TADAWUL:4005)
Oct 19National Medical Care (TADAWUL:4005) Is Doing The Right Things To Multiply Its Share Price
Aug 15National Medical Care's (TADAWUL:4005) Returns On Capital Are Heading Higher
May 13Earnings Update: National Medical Care Company (TADAWUL:4005) Just Reported Its Annual Results And Analysts Are Updating Their Forecasts
Mar 03A Look At The Fair Value Of National Medical Care Company (TADAWUL:4005)
Feb 10Returns At National Medical Care (TADAWUL:4005) Appear To Be Weighed Down
Nov 10Returns On Capital At National Medical Care (TADAWUL:4005) Have Hit The Brakes
Jul 02Estimating The Intrinsic Value Of National Medical Care Company (TADAWUL:4005)
Apr 14Is National Medical Care Company (TADAWUL:4005) A Risky Dividend Stock?
Mar 25Will National Medical Care (TADAWUL:4005) Multiply In Value Going Forward?
Feb 23Update: National Medical Care (TADAWUL:4005) Stock Gained 25% In The Last Five Years
Feb 09
National Medical Care Company's (TADAWUL:4005) Stock Been Rising But Financials Look Weak: Should Shareholders Be Worried?
Jan 27Calculating The Fair Value Of National Medical Care Company (TADAWUL:4005)
Jan 14Is National Medical Care Company's (TADAWUL:4005) 3.8% Dividend Sustainable?
Dec 25Does National Medical Care's (TADAWUL:4005) Statutory Profit Adequately Reflect Its Underlying Profit?
Dec 10What Kind Of Shareholders Hold The Majority In National Medical Care Company's (TADAWUL:4005) Shares?
Nov 24CEO
Abdulaziz Alobaid
6.1yrs
Tenure
ر.س242,000
Compensation
Dr. Abdulaziz Saleh Alobaid serves as Chief Executive Officer at National Medical Care Company since January 1, 2019 and serves as its Managing Director since September 15, 2022. He was the Chief Medical O...
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Non Executive Director | no data | ر.س221.00k | no data | |
| Chairman of the Board | 5.8yrs | ر.س318.00k | no data | |
| Vice Chairman | 5.8yrs | ر.س236.00k | no data | |
| Independent Director | no data | ر.س236.00k | 0.011% SAR 831.1k | |
| Independent Director | no data | ر.س159.11k | no data | |
| Non-Executive Director | 3.6yrs | ر.س227.00k | no data | |
| Independent Director | no data | ر.س221.00k | no data | |
| Independent Director | no data | ر.س257.00k | no data | |
| Non-Executive Director | 4.7yrs | ر.س239.00k | no data |
5.2yrs
Average Tenure
Experienced Board: 4005's board of directors are considered experienced (5.2 years average tenure).
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2025/02/07 21:30 |
| End of Day Share Price | 2025/02/06 00:00 |
| Earnings | 2024/09/30 |
| Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
National Medical Care Company is covered by 11 analysts. 4 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Ibrahim Elaiwat | Aljazira Capital Company |
| Jassim Al-Jubran | Aljazira Capital Company |
| Madhu Appissa | Al Rajhi Capital |